• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型血管紧张素转换酶(ACE)抑制剂培哚普利代谢途径的种间比较

Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor.

作者信息

Grislain L, Mocquard M T, Dabe J F, Bertrand M, Luijten W, Marchand B, Resplandy G, Devissaguet M

机构信息

Bio-Pharmacie Servier, Orleans, France.

出版信息

Xenobiotica. 1990 Aug;20(8):787-800. doi: 10.3109/00498259009046893.

DOI:10.3109/00498259009046893
PMID:2219962
Abstract
  1. The metabolism of perindopril (non-thiol angiotensin-converting enzyme inhibitor) was studied in rat, dog and monkey after single oral and i.v. administration of 14C-perindopril, and in man after a single oral dose. 2. Six biotransformation products of perindopril from urine, faecal and plasma samples (bile only for rats) were identified. 3. The main route of biotransformation in all species is the hydrolysis of the carboxylic ethyl ester side-chain, with the formation of perindoprilate, the active metabolite. 4. A minor route of biotransformation led to the acyl glucuronides of perindopril and perindoprilate. 5. Internal dehydration of perindopril and perindoprilate into cyclic lactam structures occurs. This route of metabolism is of minor importance except in humans.
摘要
  1. 在大鼠、犬和猴单次口服及静脉注射14C-培哚普利后,对其代谢情况进行了研究,同时也对人类单次口服剂量后的情况进行了研究。2. 从尿液、粪便和血浆样本(仅大鼠有胆汁样本)中鉴定出了培哚普利的六种生物转化产物。3. 在所有物种中,生物转化的主要途径是羧酸乙酯侧链的水解,形成活性代谢产物培哚普利拉。4. 生物转化的次要途径导致培哚普利和培哚普利拉的酰基葡萄糖醛酸苷形成。5. 培哚普利和培哚普利拉会发生内部脱水形成环状内酰胺结构。除了在人类中,这条代谢途径的重要性较低。

相似文献

1
Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor.新型血管紧张素转换酶(ACE)抑制剂培哚普利代谢途径的种间比较
Xenobiotica. 1990 Aug;20(8):787-800. doi: 10.3109/00498259009046893.
2
Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.新型血管紧张素转换酶抑制剂咪达普利在动物体内的代谢命运。第6篇通讯:大鼠、犬和猴体内咪达普利代谢产物的药代动力学及排泄的种间比较
Arzneimittelforschung. 1992 Apr;42(4):499-506.
3
In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.口服给药后犬、小鼠和大鼠体内[14C]鲁比前列酮的代谢及其代谢产物的液相色谱/质谱和核磁共振光谱结构测定
Drug Metab Dispos. 2006 Feb;34(2):213-24. doi: 10.1124/dmd.105.007401. Epub 2005 Oct 28.
4
Biotransformation studies of di-acid angiotensin converting enzyme inhibitors.二羧酸类血管紧张素转换酶抑制剂的生物转化研究
Arzneimittelforschung. 1987 Nov;37(11):1225-8.
5
Effects of perindopril on angiotensin converting enzyme in tissues of the rat.培哚普利对大鼠组织中血管紧张素转换酶的影响。
J Hypertens Suppl. 1988 Dec;6(3):S51-4.
6
Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 5th communication: isolation and identification of metabolites of imidapril in rats, dogs, and monkeys.新型血管紧张素转换酶抑制剂咪达普利在动物体内的代谢命运。第5篇通讯:大鼠、犬和猴体内咪达普利代谢产物的分离与鉴定。
Arzneimittelforschung. 1992 Apr;42(4):490-8.
7
High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium.
Int J Tissue React. 1989;11(2):81-92.
8
Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.新型血管紧张素转换酶抑制剂咪达普利在动物体内的代谢命运。首次通讯:在大鼠和犬体内的吸收、药代动力学及排泄
Arzneimittelforschung. 1992 Apr;42(4):457-65.
9
[Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues].[血管紧张素转换酶未来前景研讨会。新型强效血管紧张素转换酶抑制剂培哚普利的介绍。培哚普利能有效且迅速地抑制血浆及组织中的血管紧张素转换酶]
Med Clin (Barc). 1991 Apr 27;96(16):suppl 2 p..
10
Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
Can J Cardiol. 1994 Nov;10 Suppl D:13D-16D.

引用本文的文献

1
Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects.使用基于生理的药代动力学模型同时预测肝硬化受试者中CES1代谢药物及其代谢物的药代动力学
Pharmaceutics. 2024 Feb 5;16(2):234. doi: 10.3390/pharmaceutics16020234.
2
Effects of Chungsinoryungsan, a polyherbal complex, on the pharmacokinetic profiles of perindopril in rats.多草药复方中辛龙根散对大鼠培哚普利药代动力学特征的影响。
Biomed Rep. 2014 Nov;2(6):855-860. doi: 10.3892/br.2014.330. Epub 2014 Aug 5.
3
Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.
培哚普利。对其药理特性及在心血管疾病治疗中的应用综述。
Drugs. 1991 Jul;42(1):90-114. doi: 10.2165/00003495-199142010-00006.
4
The pharmacokinetics of perindopril in patients with liver cirrhosis.培哚普利在肝硬化患者中的药代动力学。
Br J Clin Pharmacol. 1992 Mar;33(3):326-8. doi: 10.1111/j.1365-2125.1992.tb04045.x.